Navigation Links
Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions
Date:11/30/2009

KALAMAZOO, Mich., Nov. 30 /PRNewswire-FirstCall/ -- Stryker Corporation (NYSE: SYK) today announced a definitive agreement to acquire privately held Ascent Healthcare Solutions, Inc. the market leader in the reprocessing and remanufacturing of medical devices in the U.S.

Under the terms of the agreement, Stryker will acquire Ascent Healthcare Solutions for $525 million in an all cash transaction. The closing is conditioned on the expiration or termination of all applicable waiting periods pursuant to the Hart-Scott-Rodino Antitrust Improvements Act and other customary closing conditions. The board of directors of Stryker and the board of directors and shareholders of Ascent Healthcare Solutions have approved the transaction.

Ascent Healthcare Solutions was formed through the 2005 merger of Vanguard Medical Concepts and Alliance Medical Corporation, two leading players in the reprocessing and remanufacturing of medical devices. With two state of the art reprocessing facilities in Phoenix, Arizona and Lakeland, Florida, Ascent currently provides its services to 1,800 leading hospitals and numerous Group Purchasing Organizations throughout North America. Ascent's market leadership position has been driven by its broad product offering, which includes cardiovascular, orthopaedics, gastroenterology and general surgery devices that must comply with the U.S. Food and Drug Administration's 510(k) and Quality System Regulation (QSR) requirements. With over 900 team members, Ascent achieved sales in 2008 in excess of $100 million.

"The acquisition of Ascent Healthcare Solutions with its talented team will enhance our value proposition to hospitals and healthcare providers," said Stephen P. MacMillan, Stryker's Chief Executive Officer. "Conducted in accordance with FDA regulations, reprocessing and remanufacturing is o
'/>"/>

SOURCE Stryker Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Stryker To Host Conference Call on October 20, 2009
2. Stryker Announces Election of New Director
3. Stryker Operating Results for Quarter Ended June 30, 2009
4. Stryker to Host Conference Call on July 21, 2009
5. Stryker Announces Election of New Director
6. Stryker Operating Results for Quarter Ended March 31, 2009
7. Stryker to Provide Webcast and Telephone Access to Annual Shareholder Meeting
8. Stryker to Host Conference Call on April 20, 2009
9. Stryker to Host Analyst Meeting
10. Stryker Operating Results for Quarter Ended December 31, 2008
11. LegalView Developing Cranial Implant Information Portal Detailing the Recall of Stryker Cranial Implant Kits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 2015 Dr. St. Ledger recently returned from ... Dental Education. Here, he participated in the Worn Dentition ... a greater predictability in cases of severely worn teeth, as ... wear, and the correlation to GERD and Sleep Apnea. ... Spear Education. After the workshop he attended, he mentored ...
(Date:3/31/2015)... NJ (PRWEB) March 31, 2015 At Summit ... to all patients in a calm and caring manner. , ... the diagnosis and surgical treatment of breast cancer. They ... area but from all over the world. Their doctors ... local publications. , The seeds for Summit Breast Care were ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Dr. Uzma Parvez ... March 19th, Dr. Parvez conducted Grand Grounds Presentations at St. ... Opioids and Managing Side Effects”. The event was attended ... She received very positive feedback from the Grand Rounds. ... best that they’ve had in a while. , Ahead, ...
(Date:3/31/2015)... 31, 2015 Beckman Coulter is sponsoring a ... 787: “Subvisible Particulate Matter in Therapeutic Protein Injections”,” an educational ... demands in counting particles in liquids, with a focus on ... is free to attend and will be broadcast live April ... a new test for protein-based materials, known as USP ...
(Date:3/31/2015)... 31, 2015 Former 49ers linebacker Chris Borland ... his first year of a promising NFL career. In a ... Earth Senior Writer Will Leitch explores the curious case ... talks about the decision making process that Borland and other ... health over a large paycheck, and what impact, if any, ...
Breaking Medicine News(10 mins):Health News:The dentists at Upper Montclair Dental Associates are happy to announce exciting new happenings at their practice. 2Health News:Summit Breast Care is Celebrating Four Years as "NJ Top Docs" 2Health News:NJ Top Docs Presents, Dr. Uzma Parvez of Total Pain Care 2Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 2Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 3Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 3
... Leading Urology Annual MeetingSUNNYVALE, Calif., April 23 Accuray ... in the field of radiosurgery, announced today that more ... date worldwide using the CyberKnife(R) Robotic Radiosurgery System. In ... approximately 400 prostate cancer patients were treated. The company ...
... LOUIS, April 23 Sigma-Aldrich Corporation, a leading Life Science ... diluted EPS grew by 6% to $0.68 from $0.64 in ... of 2009 were $519 million, a decline of 9% from ... first quarter sales grew organically by 1% from a year ...
... BEACH, Fla., April 23 The Cosmetic Bootcamp LLC announces ... in Aspen, Colorado. Leading skin care experts from dermatology and ... event was made possible by a generous grant from Johnson ... in ethnic skincare. Among the faculty attending this meeting will ...
... PARK, N.J., April 23 OTC Perspectives - a ... company DTC Perspectives Inc. - has announced the finalists ... leading healthcare brands named as finalists are Aleve, Benadryl, ... winners of OTC National Advertising Awards will be announced ...
... Conn., April 23 CuraGen Corporation (Nasdaq: ... first quarter of 2009. During the three month period ... and investments for operations and repurchased $4.8 million of debt ... million of cash and investments. As of March ...
... 23 April: The first identification of GP130 ... today at EASL 2009, the Annual Meeting of ... Disease in Copenhagen, Denmark. , Identification of recurrent ... reveals a new pathway of tumourigenesis in humans, ...
Cached Medicine News:Health News:CyberKnife Radiosurgery Used to Treat More Than 3,000 Prostate Cancer Patients Worldwide 2Health News:CyberKnife Radiosurgery Used to Treat More Than 3,000 Prostate Cancer Patients Worldwide 3Health News:CyberKnife Radiosurgery Used to Treat More Than 3,000 Prostate Cancer Patients Worldwide 4Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 2Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 3Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 4Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 5Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 6Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 7Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 8Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 9Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 10Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 11Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 12Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 13Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 14Health News:Sigma-Aldrich (Nasdaq: SIAL) Reports 6% Increase In First Quarter 2009 Diluted EPS to $0.68. All Research Units Achieve Organic Sales Growth. Full Year 2009 Guidance Reaffirmed; Diluted EPS Expected to Exceed Reported EPS for 2008 of $2.65. 15Health News:J&J, Schering-Plough, Novartis, Bayer vie for Top Honors at the Premier OTC / Healthcare Ad Awards 2Health News:CuraGen Reports First Quarter 2009 Financial Results 2Health News:CuraGen Reports First Quarter 2009 Financial Results 3Health News:CuraGen Reports First Quarter 2009 Financial Results 4Health News:CuraGen Reports First Quarter 2009 Financial Results 5Health News:New oncogene gives valuable insight into hepatocellular tumors in humans 2
(Date:3/31/2015)... , March 31, 2015  The efficacy of continuous ... in a recently published study 1 of ultraviolet ... research team, including Curtis Donskey , M.D.  The ... for the same length of time from the same ... unit.  The results showed surprisingly low pathogen kill rates ...
(Date:3/31/2015)... 31, 2015 According to ... Chemical Instrumentation Market (Chromatography, Electrophoresis, DNA Sequencer, PCR, Microplate ... Fume Hood, Centrifuge) - Global Forecast to 2019", ... Chemical Instrumentation Market is expected to reach $48.84 ... 2014 to 2019. Browse   ...
(Date:3/31/2015)... March 31, 2015  Frequentz Inc., a global leader ... white paper to help the pharmaceutical industry understand the ... Chain Security Act (DSCSA). The white paper, "From Lot-based ... GS1 EPCIS Standard(s) and Implementation Plan rollout, ... product tracing requirements that need to occur between now ...
Breaking Medicine Technology:VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 2Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 5Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 2Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 3
... Nov. 4 Sanford Wittels & Heisler, LLP, along ... a medical device company specializing in cardiac surgical ablation ... Department of Justice (DOJ) in a qui tam case ... a five-year period. , Sanford Wittels & Heisler and ...
... 4 NeoStem, Inc. (NYSE Amex: NBS ), ... named to the Company,s Board of Directors. Dr. ... biotechnology businesses. , Serving as Executive Vice President of ... operations of Abraxis Bioscience, a global biotechnology company dedicated ...
Cached Medicine Technology:Relator's Attorneys Comment On AtriCure/DOJ Proposed Settlement 2NeoStem, Inc. Names Edward Geehr, M.D. to Board of Directors; Biotechnology Executive Brings Scientific and Business Experience in Global Operations 2NeoStem, Inc. Names Edward Geehr, M.D. to Board of Directors; Biotechnology Executive Brings Scientific and Business Experience in Global Operations 3
... Leica ASP300 smart tissue processor features superior ... ASP300 is a fully enclosed, stand-alone system ... samples. This new tissue processor combines proven ... touch screen and easy to use,yet powerful ...
... 120 represents a new tissue infiltration instrument, ... a masterly way. The robust caroussel design ... smallest space. The instrument includes either 10 ... reagent and 3 paraffin containers. Up to ...
... electronic, motorized rotary microtomes ... applications of paraffin, semi-thin ... specimens in clinical, research, ... instruments display extra-ordinary ergonomic ...
... heavy-duty sectioning system is the standard microtome for ... real working animal. ,Large specimens up to 250 ... bone or teeth and whole organs (brain, lung, ... accessories, specially designed for paraffin and resin embedded ...
Medicine Products: